This observation may be indicative of higher levels of RPSA in CRC although an increase in 67EBP cannot be excluded considering the cross-reactivity of the anti-RPSA antibodies with 67EBP previously observed and the identification of putative sequences responsible for the cross-reactivity [27]. The gene discussed is RPSA; the disease is colorectal carcinoma.